SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-23-001332
Accepted
2023-05-09 00:15:16
Documents
1
Effectiveness Date
2023-05-08
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 598
  Complete submission text file 9999999995-23-001332.txt   1719
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-270921 | Film No.: 23899744
SIC: 2834 Pharmaceutical Preparations